Temozolomide treatment for newly diagnosed anaplastic oligodendrogliomas: a clinical efficacy trial

Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse

W.K. Alfred Yung, Michael D. Prados, Ricardo Yayá et al. · Journal of Clinical Oncology · 1999 · 763 citations

Medicine, Oncology, Pharmacotherapy +17

Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group.

Gregory Cairncross, David Macdonald, Samuel K. Ludwin et al. · Journal of Clinical Oncology · 1994 · 443 citations

Medicine, Oncology, Radiation Oncology +17

Phase II Study of First-Line Chemotherapy With Temozolomide in Recurrent Oligodendroglial Tumors: The European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971

Martin J. van den Bent, Alba A. Brandes, Johan Menten et al. · Journal of Clinical Oncology · 2003 · 296 citations

Medicine, Oncology, Surgery +17

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy

Martin J. van den Bent, J. Kros, J.J. Heimans et al. · Neurology · 1998 · 203 citations

Medicine, Oncology, Pharmacology +16

Safety and Efficacy of Temozolomide in Patients With Recurrent Anaplastic Oligodendrogliomas After Standard Radiotherapy and Chemotherapy

Stéphane Honoré, Henry Dufour, Maryline Barrié et al. · Journal of Clinical Oncology · 2001 · 177 citations

Medicine, Oncology, Pharmacology +17